Dr. Farhad Rikhtegar Nezami received his PhD in Mechanical Engineering from Swiss Federal Institute of Technology (ETH Zurich) in October 2013 under the supervision of Prof. Dimos Poulikakos and Prof. Vartan Kurtcuoglu. His doctoral studies focused on developing a compound ex vivo and in silico method to study blood flow and drug delivery in stented coronary arteries. He closely collaborated with University Hospital Zurich and two industrial partners (BiotroniK and PSI). He completed his master's and bachelor's degrees at Sharif University of Technology and Amirkabir University of Technology in Tehran, respectively.

 After short period of postdoctoral affiliation and visiting in Switzerland, Farhad joined as a postdoctoral fellow to Harvard-MIT Biomedical Engineering Center (HMBEC) at MIT under supervision of Prof. Elazer Edelman. His research at HMBEC, now as a research scientist and project leader, is mainly focused on leveraging understanding biomechanics, and successful translation of state-of-the-art technologies from bench top tests, engineering platforms and preclinical experiments to clinical practices. He uses data-driven computational models to develop tractable and provably-reliable engineering test systems and numerical platformsto to provide mechanistic understanding of diseases, and assess and optimize the efficacy of medical devices. The geometrical and mechanical features extracted from computational simulations serve machine-learning algorithms and data analysis routines to provide predictive/prognostic means, diagnostic tools, and surgical guidelines for clinicians. To this end, He capitalizes tools from computational modeling (computational fluid dynamics, solid mechanics, mass transport phenomena and mathematical modeling), image processing, informatics, and in vitro and ex/in vivo experiments.